Autoimmune channelopathies of the nervous system

Current Neuropharmacology

Volumn 9, Issue 3, 2011, Pages 458-467

  Kleopa, Kleopas A ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Autoimmunity; Glutamate receptors; Ion channels; Lambert eaton myasthenic syndrome; Limbic encephalitis; Morvan's syndrome; Neuromyotonia; Voltage gated potassium channels; Voltage gated calcium channels

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR ANTIBODY; AMPA RECEPTOR ANTIBODY; ANTIBODY; AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; BUNGAROTOXIN RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMMUNOGLOBULIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; STEROID; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTONOMIC NEUROPATHY; CEREBELLAR ATAXIA; CHANNELOPATHY; CHOREA; EATON LAMBERT SYNDROME; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EPILEPSY; HUMAN; HYPEREKPLEXIA; IMMUNOADSORPTION; MOLECULAR MECHANICS; MORGAN SYNDROME; MORVAN SYNDROME; MYELOOPTIC NEUROPATHY; MYOKYMIA; NERVE CONDUCTION; NEUROLOGIC DISEASE; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; PLASMAPHERESIS; STEROID THERAPY;

EID: 79961016156     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015911796557966     Document Type: Article

References (118)

1. Albert, M.L., Austin, L.M., Darnell, R.B. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann. Neurol., 2000, 47(1), 9-17.
2. Benyahia, B., Liblau, R., Merle-Beral, H., Tourani, J.M., Dalmau, J., Delattre, J.Y. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann. Neurol., 1999, 45(2), 162-167.
3. Graus, F., Vega, F., Delattre, J.Y., Bonaventura, I., Reñé, R., Arbaiza, D., Tolosa, E. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoanti-bodies. Neurology, 1992, 42, 536-540.
4. Shams'ili, S., Grefkens, J., de Leeuw, B., van den Bent, M., Hooijkaas, H., van der Holt, B., Vecht, C., Sillevis, S.P. Para-neoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain, 2003, 126, 1409-1418.
5. Vincent, A., Buckley, C., Schott, J.M., Baker, I., Dewar, B.K., Detert, N., Clover, L., Parkinson, A., Bien, C.G., Omer, S., Lang, B., Rossor, M.N., Palace, J. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain, 2004, 127, 701-712.
6. Thieben, M.J., Lennon, V.A., Boeve, B.F., Aksamit, A.J., Keegan, M., Vernino, S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology, 2004, 62(7), 1177-1182.
7. Sinha, S., Newsom-Davis, J., Mills, K., Byrne, N., Lang, B., Vincent, A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet, 1991, 338(8759), 75-77.
8. Shillito, P., Molenaar, P.C., Vincent, A., Leys, K., Zheng, W., van den Berg, R.J., Plomp, J.J., Van Kempen, G.T.H., Chauplannaz, G., Wintzen, A.R., Vandijk, J.G., Newsom-Davis, J. Acquired neuro-myotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann. Neurol., 1995, 38, (5), 714-722.
9. Tomimitsu, H., Arimura, K., Nagado, T., Watanabe, O., Otsuka, R., Kurono, A., Sonoda, Y., Osame, M., Kameyama, M. Mechanism of action of voltage-gated K+ channel antibodies in acquired neuro- myotonia. Ann. Neurol., 2004, 56, 440-444.
10. Nagado, T., Arimura, K., Sonoda, Y., Kurono, A., Horikiri, Y., Kameyama, A., Kameyama, M., Pongs, O., Osame, M. Potassium current suppression in patients with peripheral nerve hyperexcita-bility. Brain, 1999, 122, 2057-2066.
11. Vincent, A., Lang, B., Kleopa, K.A. Autoimmune channelopathies and related neurological disorders. Neuron, 2006, 52(1), 123-138.
12. Buckley, C, Vincent, A. Autoimmune channelopathies. Nat. Clin. Pract. Neurol., 2005, 1(1), 22-33.
13. Dalmau, J., Rosenfeld, M.R. Paraneoplastic syndromes of the CNS. Lancet Neurol., 2008, 7(4), 327-340.
14. Eaton, L.M., Lambert, E.H. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. JAMA, 1957, 163(13), 1117-1124.
15. O'Neill, J.H., Murray, N.M., Newsom-Davis, J. The Lambert-Eaton myasthenic syndrome: a review of 50 cases. Brain, 1988, 111(3), 577-596.
16. Kleopa, K.A., Teener, J.W., Scherer, S.S., Galetta, S.L., Bird, S.J. Chronic multiple paraneoplastic syndromes. Muscle Nerve, 2000, 23(11), 1767-1772.
17. Lambert, E.H., Elmqvist, D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann. N. Y. Acad. Sci., 1971, 183, 183-99.
18. Elmqvist, D., Lambert, E.H. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin. Proc., 1968, 43(10), 689-713.
19. Fukunaga, H., Engel, A.G., Lang, B., Newsom-Davis, J., Vincent, A. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc. Natl. Acad. Sci. USA, 1983, 80(24), 7636-7640.
20. Lang, B., Newsom-Davis, J., Peers, C., Prior, C., Wray, D.W. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J. Physiol., 1987, 390, 257-270.
21. Lennon, V.A., Kryzer, T.J., Griesmann, G.E., O'Suilleabhain, P.E., Windebank, A.J., Woppmann, A., Miljanich, G.P., Lambert, E.H. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N. Engl. J. Med., 1995, 332, 1467-1474.
22. Tim, R.W., Massey, J.M., Sanders, D.B. Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment. Neurology 2000, 54(11), 2176-2178.
23. Catterall, W.A. Structure and regulation of voltage-gated Ca2+ channels. Annu. Rev. Cell Devel. Biol., 2000, 16, 521-555.
24. Sher, E., Gotti, C., Canal, N., Scoppetta, C., Piccolo, G., Evoli, A., Clementi, F. Specificity of calcium channel autoantibodies in Lam-bert-Eaton myasthenic syndrome. Lancet, 1989, 2, 640-643.
25. Verschuuren, J.J., Dalmau, J., Tunkel, R., Lang, B., Graus, F., Schramm, L., Posner, J.B., Newsom-Davis J., Rosenfeld M.R. An-tibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome. Neurology, 1998, 50, 475-479.
26. Motomura, M., Johnston, I., Lang, B., Vincent, A., Newsom-Davis, J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J. Neurol. Neurosurg. Psychiatry 1995, 58(1), 85-87.
27. Roberts, A., Perera, S., Lang, B., Vincent, A., Newsom-Davis, J. Paraneoplastic myasthenic syndrome IgG inhibits Ca2+ flux in a human small cell carcinoma line. Nature, 1985, 317(6039), 737-739.
28. Pellkofer, H.L., Armbruster, L., Krumbholz, M., Titulaer, M.J., Verschuuren, J.J., Schumm, F., Voltz, R. Lambert-eaton myas-thenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel. J. Neuro-immunol., 2008, 204, 136-139.
29. Sabater, L., Titulaer, M., Saiz, A., Verschuuren, J., Güre, A.O., Graus, F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology, 2008, 70(12), 924-928.
30. Payne, M., Bradbury, P., Lang, B., Vincent, A., Han, C., Newsom-Davis, J., Talbot, D.P. Prospective study into the incidence of Lam-bert Eaton myasthenic syndrome in small cell lung cancer. J. Tho-rac. Oncol., 2010, 5, 34-38.
31. Flet, L., Polard, E., Guillard, O., Leray, E., Allain, H., Javaudin, L., Edan, G. 3, 4-Diaminopyridine safety in clinical practice: an obser- vational, retrospective cohort study. J. Neurol., 2010, 257(6), 937-46.
32. Newsom-Davis, J. A treatment algorithm for Lambert-Eaton myasthenic syndrome. Ann. N. Y. Acad. Sci., 1998, 841, 817-822.
33. Pellkofer, H.L., Voltz, R., Kuempfel, T. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction. Muscle Nerve, 2009, 40(2), 305-308.
34. Mason, W., Graus, F., Lang, B., Honnorat, J., Delattre, J., Vall-Deoriola, F., Antoine, J., Rosenblum, M., Rosenfeld, M., Newsom-Davis, J., Posner, J., Dalmau, J. Small-cell lung cancer, paraneo-plastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain, 1997, 120, 1279-1300.
35. Peterson, K., Rosenblum, M.K., Kotanides, H., Posner, J.B. Para-neoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology, 1992, 42(10), 1931-1937.
36. Graus, F., Lang, B., Pozo-Rosich, P., Saiz, A., Casamitjana, R., Vincent, A. P/Q-type calcium channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology, 2002, 59(5), 764-766.
37. Pinto, A., Gillard, S., Moss, F., Whyte, K., Burst, P., Williams, M., Stauderman, K., Harpold, M., Lang, B., Newsom-Davis, J., Bleak-Man, D., Lodge, D., Boot, J. Human autoantibodies specific for a1A calcium channel subunit reduce both P-type and Q-type cal-cium channels in cerebellar neurons. Proc. Natl. Acad. Sci. U.S.A., 1998, 95, 8328-8333.
38. Oguro-Okano, M., Griesmann, G.E., Wieben, E.D., Slaymaker, S.J., Snutch, T.P., Lennon, V.A. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin. Proc. 1992, 67(12), 1150-1159.
39. Jun, K., Piedras-Renteria, E.S., Smith, S.M., Wheeler, D.B., Lee, S.B., Lee, T.G., Chin, H., Adams, M.E., Scheller, R.H., Tsien, R.W., Shin, H.S. Ablation of P/Q-type Ca(2) channel currents, altered synaptic transmission, and progressive ataxia in mice lack- ing the alpha(1A)-subunit. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 15245-15250.
40. Fukuda, T., Motomura, M., Nakao, Y., Shiraishi, H., Yoshimura, T., Iwanaga, K., Tsujihata, M., Eguchi, K. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann. Neurol., 2003, 53, 21-28.
41. Liao, Y.J., Safa, P., Chen, Y.R., Sobel, R.A., Boyden, E.S., Tsien, R.W. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo. Proc. Natl. Acad. Sci. U.S.A., 2008, 105(7), 2705-2710.
42. Hart, I., Maddison, P., Newsom-Davis, J., Vincent, A., Mills, K. Phenotypic variants of autoimmune peripheral nerve hyper- excitability. Brain, 2002, 125(8), 1887-1895.
43. Kleopa, K.A., Barchi, R.L. Genetic disorders of neuromuscular ion channels. Muscle Nerve, 2002, 26(3), 299-325.
44. Lance, J.W., Burke, D., Pollard, J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann. Neurol., 1979, 5(6), 523-532.
45. Newsom-Davis, J., Mills, K.R. Immunological associations of acquired neuromyotonia (Isaacs syndrome) - report of five cases and literature review. Brain, 1993, 116(2), 453-569.
46. Arimura, K., Arimura, Y., Ng, A., Uehara, A., Nakae, M., Osame, M., Stalberg, E. The origin of spontaneous discharges in acquired neuromyotonia. A Macro EMG study. Clin. Neurophysiol., 2005, 116, 1835-1839.
47. Maddison, P., Mills, K.R., Newsom-Davis, J. Clinical electro- physiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability. Muscle Nerve, 2006, 33(6), 801-808.
48. Hart, I.K., Waters, C., Vincent, A., Newland, C., Beeson, D., Pongs, O., Morris, C., Newsom-Davis, J. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann.Neurol., 1997, 41, 238-246.
49. Kleopa, K.A., Elman, L., Lang, B., Vincent, A., Scherer, S.S. Neuromyotonia and limbic encephalitis sera target mature Shaker- type K+ channels: subunit specificity correlates with clinical manifestations. Brain, 2006, 129(6), 1570-1584.
50. Newsom-Davis, J. Autoimmune Neuromyotonia (Isaac's syndrome): An antibody-mediated potassium channelopathy. Ann. N.Y. Acad. Sci., 1997, 835, 111-119.
51. Morvan, A. De la chorée fibrillaire. Gaz. Hebd. Mèd. Chir., 1890, 27, 173-200.
52. Lee, E., Maselli, R., Ellis, W., Agius, M. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J. Neurol. Neurosurg. Psychiatry, 1998, 65(6), 857-862.
53. Liguori, R., Vincent, A., Clover, L., Avoni, P., Plazzi, G., Cortelli, P., Baruzzi, A., Carey, T., Gambetti, P., Lugaresi, E., Montagna, P. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain, 2001, 124, 2417-2426.
54. Barber, P.A., Anderson, N.E., Vincent, A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology, 2000, 54(3), 771-772.
55. Halbach, M., Homberg, V., Freund, H.J. Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody. J. Neurol., 1987, 234(6), 433-436.
56. Madrid, A., Gil-Peralta, A., Gil-Néciga, E., González, J.R., Jarrín, S. Morvan's fibrillary chorea: remission after plasmapheresis. J. Neurol., 1996, 243(4), 350-353.
57. Heidenreich, F., Vincent, A. Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy. Neurology, 1998, 50(5), 1483-1485.
58. Antozzi, C., Frassoni, C., Vincent, A., Regondi, M.C., Andreetta, F., Bernasconi, P., Ciano, C., Chang, T., Cornelio, F., Spreafico, R., Mantegazza, R. Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology, 2005, 64, 1290-1293.
59. Buckley, C., Oger, J., Clover, L., Tuzun, E., Carpenter, K., Jack-Son, M., Vincent, A. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann. Neurol., 2001, 50, 73-78.
60. Iranzo, A., Graus, F., Clover, L., Morera, J., Bruna, J., Vilar, C., Martinez-Rodriguez, J.E., Vincent, A., Santamaria, J. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann. Neurol., 2006, 59, 178-181.
61. Jacob, S., Irani, S.R., Rajabally, Y., Grubneac, A., Walters, R.J., Yazaki, M., Clover, L., Vincent, A. Hypothermia in VGKC antibody-associated limbic encephalitis. J. Neurol. Neurosurg. Psychiatry, 2008, 79, 202-204.
62. Tuzun, E., Dalmau, J. Limbic encephalitis and variants: classifica- tion, diagnosis and treatment. Neurologist, 2007, 13(5), 261-271.
63. Pozo-Rosich, P., Clover, L., Saiz, A., Vincent, A., Graus, F. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann. Neurol., 2003, 54(4), 530-533.
64. Zuliani, L., Saiz, A., Tavolato, B., Giometto, B., Vincent, A., Graus, F. Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour. J. Neurol. Neurosurg. Psychiatry, 2007, 78(2), 204-205.
65. Ances, B.M., Vitaliani, R., Taylor, R.A., Liebeskind, D.S., Volo- schin, A., Houghton, D.J., Galetta, S.L., Dichter, M., Alavi, A., Rosenfeld, M.R., Dalmau, J. Treatment-responsive limbic encepha-litis identified by neuropil antibodies: MRI and PET correlates. Brain, 2005, 128, 1764-1777.
66. Jarius, S., Hoffmann, L., Clover, L., Vincent, A., Voltz, R. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J. Neurol. Sci., 2007, 268(1), 74-77.
67. Bataller, L., Kleopa, K.A., Wu, G., Rossi, J.E., Rosenfeld, M.R., Dalmau, J. Autoimmune Limbic Encephalitis in 39 Patients: Immunophenotypes and Outcomes. J. Neurol. Neurosurg. Psychiatry, 2007, 78(4), 381-385.
68. Majoie, H.J., de Baets, M., Renier, W., Lang, B., Vincent, A. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res., 2006, 71(2-3), 135-141.
69. Antozzi, C., Binelli, S., Frassoni, C., Ciano, C., Vincent, A., Andreetta, F., Panzica, F., Franceschetti, S., Confalonieri, P., Mantegazza, R. Immunotherapy responsive startle with antibodies to voltage gated potassium channels. J. Neurol. Neurosurg. Psychiatry, 2007, 78, 1281-1290.
70. Dedek, K., Kunath, B., Kananura, C., Reuner, U., Jentsch, T.J., Steinlein, O.K. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc. Natl. Acad. Sci. U.S.A., 2001, 98(21), 12272-12277.
71. Eunson, L.H., Rea, R., Zuberi, S.M., Youroukos, S., Panayiotopoulos, C.P., Liguori, R., Avoni, P., McWilliam, R.C., Stephenson, J.B.P., Hanna, M.G., Kullmann, D.M., Spauschus, A. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann. Neurol., 2000, 48, 647-656.
72. Smart, S.L., Lopantsev, V., Zhang, C.L., Robbins, C.A., Wang, H., Chiu, S.Y., Schwartzkroin, P.A., Messing, A., Tempel, B.L. Deletion of the Kv1.1 potassium channel causes epilepsy in mice. Neuron, 1998, 20, (4), 809-819.
73. McKnight, K., Jiang, Y., Hart, Y., Cavey, A., Wroe, S., Blank, M., Shoenfeld, Y., Vincent, A., Palace, J., Lang, B. Serum antibodies in epilepsy and seizure-associated disorders. Neurology, 2005, 65, 1730-1736.
74. Jan, L.Y., Jan, Y.N. Voltage-gated and inwardly rectifying potassium channels. J. Physiol. 1997, 505(2), 267-282.
75. Catterall, W.A. Structure and function of voltage-sensitive ion channels. Science, 1988, 242(4875), 50-61.
76. MacKinnon, R. Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature, 1991, 350(6315), 232-235.
77. Abbott, G.W., Butler, M.H., Bendahhou, S., Dalakas, M.C., Ptacek, L.J., Goldstein, S.A.N. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell, 2001, 104(2), 217-231.
78. + channels in terminal and juxtaparanodal regions of neurons. Nature, 1993, 365(6441), 75-79.
79. Arroyo, E., Scherer, S. On the molecular architecture of myelinated fibers. Histochem. Cell Biol., 2000, 113(1), 1-18.
80. Safronov, B.V., Kampe, K., Vogel, W. Single voltage-dependent potassium channels in rat peripheral nerve membrane. J. Physiol., 1993, 460, 675-91.
81. Reid, G., Scholz, A., Bostock, H., Vogel, W. Human axons contain at least five types of voltage-dependent potassium channel. J. Physiol., 1999, 518(3), 681-696.
82. Veh, R.W., Lichtinghagen, R., Sewing, S., Wunder, F., Grumbach, I.M., Pongs, O. Immunohistochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain. Eur. J. Neurosci., 1995, 7(11), 2189-2205.
83. Browne, D.L., Gancher, S.T., Nutt, J.G., Brunt, E.R.P., Smith, E.A., Kramer, P., Litt, M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet., 1994, 8, 136-140.
84. Chung, Y., Shin, C., Kim, M., Lee, B., Cha, C. Immuno-histochemical study on the distribution of six members of the Kv1 channel subunits in the rat cerebellum. Brain Res., 2001, 895, 173-177.
85. + channel subunit in different neurons of rat brain. J. Neurosci., 1994, 14(4), 2408-2417.
86. Wang, H., Kunkel, D.D., Schwartzkroin, P.A., Tempel, B.L. Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J. Neurosci., 1994, 14(8), 4588-4599.
87. Monaghan, M.M., Trimmer, J.S., Rhodes, K.J. Experimental localization of Kv1 family voltage-gated K+ channel alpha and beta subunits in rat hippocampal formation. J. Neurosci., 2001, 21(16), 5973-5983.
88. Johnston, D., Hoffman, D., Magee, J., Poolos, N., Watanabe, S., Colbert, C., Migliore, M. Dendritic potassium channels in hippo-campal pyramidal neurons. J. Physiol., 2000, 525, 75-81.
89. Sonoda, Y., Arimura, K., Kurono, A., Suehara, M., Kameyama, M., Minato, S., Hayashi, A., Osame, M. Serum of Isaacs' syndrome suppresses potassium channels in PC-12 cell lines. Muscle Nerve, 1996, 19, 1439-1446.
90. Nagado, T., Arimura, K., Sonoda, Y., Kurono, A., Horikiri, Y., Kameyama, A., Kameyama, M., Pongs, O., Osame, M. Potassium current suppression in patients with peripheral nerve hyperexcita-bility. Brain, 1999, 122, 2057-2066.
91. Vernino, S., Low, P.A., Fealey, R.D., Stewart, J.D., Farrugia, G., Lennon, V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med., 2000, 343(12), 847-855.
92. Vernino, S. Antibody testing as a diagnostic tool in autonomic disorders. Clin. Auton. Res., 2009, 19(1), 13-19.
93. Sandroni, P., Vernino, S., Klein, C.M., Lennon, V.A., Benrud-Larson, L., Sletten, D.P.A. L. Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch. Neurol., 2004, 61, 44-48.
94. Lennon, V.A., Ermilov, L.G., Szurszewski, J.H., Vernino, S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Invest., 2003, 111(6), 907-13.
95. Vernino, S., Ermilov, L.G., Sha, L., Szurszewski, J.H., Low, P.A., Lennon, V.A. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci., 2004, 24(32), 7037-7042.
96. Modoni, A., Mirabella, M., Madia, F., Sanna, T., Lanza, G., Tonali, P.A., Silvestri, G. Chronic autoimmune autonomic neuropathy responsive to immunosuppressive therapy. Neurology, 2007, 68, 161-162.
97. Dalmau, J., Tüzün, E., Wu, H.Y., Masjuan, J., Rossi, J.E., Voloschin, A., Baehring, J.M., Shimazaki, H., Koide, R., King, D. Mason, W., Sansing, L.H., Dichter, M.A., Rosenfeld, M.R., Lynch, D.R. Paraneoplastic anti-N-methyl-D-aspartate receptor encephali-tis associated with ovarian teratoma. Ann. Neurol., 2007, 61, 25-36.
98. Dalmau, J., Gleichman, A.J., Hughes, E.G., Rossi, J.E., Peng, X., Lai, M., Dessain, S.K., Rosenfeld, M.R., Balice-Gordon, R., Lynch, D.R. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol., 2008, 7, 1091-1098.
99. Shimazaki, H., Ando, Y., Nakano, I., Dalmau, J. Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J. Neurol. Neurosurg. Psychiatry, 2007, 78(3), 324-325.
100. Novillo-Lopez, M.E., Rossi, J.E., Dalmau, J., Masjuan, J. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology, 2008, 70(9), 728-729.
101. Iizuka, T., Sakai, F., Ide, T., Monzen, T., Yoshii, S., Iigaya, M., Suzuki, K., Lynch, D.R., Suzuki, N., Hata, T., Dalmau, J. Anti- NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology, 2008, 70(7), 504-11.
102. Dale, R.C., Irani, S.R., Brilot, F., Pillai, S., Webster, R., Gill, D., Lang, B., Vincent, A. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann. Neurol., 2009, 66, 704-709.
103. Florance, N.R., Davis, R.L., Lam, C., Szperka, C., Zhou, L., Ahmad, S., Campen, C.J., Moss, H., Peter, N., Gleichman, A.J., Glaser, C.A., Lynch, D.R., Rosenfeld, M.R., Dalmau, J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann. Neurol., 2009, 66, 11-18.
104. Niehusmann, P., Dalmau, J., Rudlowski, C., Vincent, A., Elger, C.E., Rossi, J.E., Bien, C.G. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch. Neurol., 2009, 66, 458-464.
105. Kowal, C., DeGiorgio, L., Lee, J., Edgar, M., Huerta, P., Volpe, B., Diamond, B. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA., 2006, 103, 19854-19859.
106. Lai, M., Hughes, E.G., Peng, X., Zhou, L., Gleichman, A.J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M.D., Bataller, L., Kalb, R.G., Davis, R., Graus, F., Lynch, D.R., Balice-Gordon, R., Dalmau, J. AMPA receptor antibodies in limbic en- cephalitis alter synaptic receptor location. Ann. Neurol., 2009, 65, 424-434.
107. Rogers, S.W., Andrews, P.I., Gahring, L.C., Whisenand, T., Cauley, K., Crain, B., Hughes, T.E., Heinemann, S.F., McNamara, J.O. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science, 1994, 265, 648-651.
108. Bien, C.G., Granata, T., Antozzi, C., Cross, J.H., Dulac, O., Kurthen, M., Lassmann, H., Mantegazza, R., Villemure, J.G., Spreafico, R., Elger, C.E. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain, 2005, 128, 454-471.
109. Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M.B., Grisold, W., Kimura, A., Ohta, K., Iizuka, T., Guzman, M., Graus, F., Moss, S.J., Balice-Gordon, R., Dalmau, J. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterization of the antigen. Lancet Neurol., 2010, 9, 67-76.
110. Wingerchuk, D.M., Lennon, V.A., Lucchinetti, C.F., Pittock, S.J., Weinshenker, B.G. The spectrum of neuromyelitis optica. Lancet Neurol., 2007, 6(9), 805-815.
111. Mandler, R.N., Ahmed, W, Dencoff, J.E. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology, 1998, 51(4), 1219-1220.
112. Lucchinetti, C.F., Mandler, R.N., McGavern, D., Bruck, W., Gleich, G., Ransohoff, R.M., Trebst, C., Weinshenker, B., Winger-Chuk, D., Parisi, J.E., Lassmann, H. A role for humoral mecha-nisms in the pathogenesis of Devic's neuromyelitis optica. Brain, 2002, 125, 1450-1461.
113. Lennon, V.A., Wingerchuk, D.M., Kryzer, T.J., Pittock, S.J., Luc-Chinetti, C.F., Fujihara, K., Nakashima, I., Weinshenker, B.G. A se- rum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet, 2004, 364, 2106-2112.
114. Lennon, V.A., Kryzer, T.J., Pittock, S.J., Verkman, A.S., Hinson, S.R. IgG marker of opticspinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med., 2005, 202(4), 473-477.
115. Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., Ito-Yama, Y. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain, 2007, 130, 1224-1234.
116. Bennett, J.L., Lam, C., Kalluri, S.R., Saikali, P., Bautista, K., Du-Pree, C., Glogowska, M., Case, D., Antel, J.P., Owens, G.P., Gilden, D., Nessler, S., Stadelmann, C., Hemmer, B. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol., 2009, 66, 617-629.
117. Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., Itoyama, Y., Lassmann, H. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol., 2009, 66, 630-643.
118. Saadoun, S., Waters, P., Anthony B.B., Vincent, A., Verkman, A.S., Papadopoulos, M.C.I. Intra-cerebral injection of neuromyelitis optica immunoglobin G and human complement produces neuromyelitis optica lesions in mice. Brain, 2010, 133(2), 349-361.